Search

everythinglearnresearchcommunity

for

Search:↓

The extract of Silybum marianum, Manganese PCA, and Lespedeza capitata can boost hair growth and extend the growth phase when combined in a serum.

The goal is to create a tool for patients to report their experiences with various hair and scalp disorders.

Injections of special skin cells showed potential in treating hair loss, with some participants experiencing increased hair density.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

An individual's morning or evening preference can predict changes in their body clock gene expression.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Noggin is necessary to start the hair growth phase in skin after birth.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Topical finasteride is an effective and safer treatment for male hair loss.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Researchers developed a quick and reliable method to test for betamethasone dipropionate and calcipotriol in ointments and drugs.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Health Education England is moving forward with phase two of their cosmetic intervention project after a successful summit and plans for future training standards.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

Etanercept is safe and may help improve hidradenitis suppurativa, but more research is needed.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Mefloquine was generally safe at 500 mg weekly, but higher doses caused nausea and diarrhea.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

The new palladium catalyst is effective and reusable for making pharmaceutical ingredients.

Temozolomide improves survival in grade III glioma patients without harming quality of life.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Created method to measure doxazosin mesylate and finasteride together.

5% minoxidil foam is effective and safe for hair regrowth in women with hair loss.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.